Raymond James & Associates Buys Shares of 1,124,215 Healthpeak Properties, Inc. (NYSE:DOC)

Raymond James & Associates purchased a new position in Healthpeak Properties, Inc. (NYSE:DOC) during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 1,124,215 shares of the real estate investment trust’s stock, valued at approximately $25,711,000. Raymond James & Associates owned about 0.16% of Healthpeak Properties at the end of the most recent reporting period.

Several other large investors also recently modified their holdings of DOC. Douglas Lane & Associates LLC bought a new position in Healthpeak Properties in the third quarter valued at about $33,947,000. Presima Securities ULC bought a new stake in shares of Healthpeak Properties during the 3rd quarter valued at about $22,465,000. AMF Tjanstepension AB purchased a new stake in shares of Healthpeak Properties during the 3rd quarter valued at about $15,548,000. Handelsbanken Fonder AB bought a new position in shares of Healthpeak Properties in the 3rd quarter worth approximately $11,668,000. Finally, Brookstone Capital Management purchased a new position in shares of Healthpeak Properties in the third quarter worth approximately $11,018,000. Institutional investors own 93.57% of the company’s stock.

Analyst Ratings Changes

A number of analysts have commented on DOC shares. Wells Fargo & Company reaffirmed an “equal weight” rating and set a $23.00 target price (up from $22.00) on shares of Healthpeak Properties in a report on Tuesday, October 1st. Citigroup raised their target price on Healthpeak Properties from $20.00 to $22.00 and gave the stock a “neutral” rating in a report on Thursday, August 22nd. Royal Bank of Canada boosted their price target on Healthpeak Properties from $22.00 to $25.00 and gave the company an “outperform” rating in a report on Tuesday, July 30th. Wedbush raised their price objective on Healthpeak Properties from $22.00 to $25.00 and gave the stock an “outperform” rating in a research note on Monday, July 29th. Finally, Evercore ISI lifted their price objective on Healthpeak Properties from $25.00 to $26.00 and gave the company an “outperform” rating in a research report on Monday, September 16th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating, nine have assigned a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, Healthpeak Properties has a consensus rating of “Moderate Buy” and an average target price of $22.62.

Healthpeak Properties Price Performance

Shares of NYSE:DOC opened at $22.99 on Friday. The firm has a market cap of $16.18 billion, a price-to-earnings ratio of 65.69, a P/E/G ratio of 2.27 and a beta of 1.14. The firm has a fifty day moving average price of $22.24 and a 200 day moving average price of $20.64. Healthpeak Properties, Inc. has a fifty-two week low of $15.24 and a fifty-two week high of $23.26. The company has a debt-to-equity ratio of 0.91, a quick ratio of 0.70 and a current ratio of 0.70.

Healthpeak Properties (NYSE:DOC) last released its quarterly earnings data on Thursday, July 25th. The real estate investment trust reported $0.21 EPS for the quarter, missing the consensus estimate of $0.44 by ($0.23). Healthpeak Properties had a net margin of 11.93% and a return on equity of 3.51%. The company had revenue of $695.50 million for the quarter, compared to the consensus estimate of $665.11 million. During the same period last year, the company earned $0.45 EPS. The firm’s revenue for the quarter was up 27.5% on a year-over-year basis. As a group, sell-side analysts expect that Healthpeak Properties, Inc. will post 1.8 earnings per share for the current fiscal year.

Healthpeak Properties Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.